Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Sleep Apnea, Obstructive 2Breast Neoplasms 2Sleep Apnea Syndromes 1Osteoporosis 1Obesity 1Myocardial Ischemia 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1Heart Diseases 1Glucose Intolerance 1Estrogen Receptor Positive Breast Cancer 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Metformin 7Testosterone 2Pioglitazone 2Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2Blood Pressure 2semaglutide 1maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Walking 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Topiramate 1Tirzepatide 1Sugars 1Spironolactone 1Qsymia 1Pyruvic Acid 1Pulse Wave Analysis 1Preoperative Exercise 1Phlebotomy 1Phentermine 1Pancreaticoduodenectomy 1Orchiectomy 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolic Syndrome × Estrogens × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡